English
简体中文
Total: £ 56.28
Published Date: 2025-02-17 | Pages: 78 | Tables: 82 | Pharma & Healthcare
The global market for Human Coagulation Factor XIII was valued at US$ 89.6 million in the year 2024 and is projected to reach a revised size of US$ 123 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Human coagulation Factor XIII (Factor XIII, abbreviated as FXIII), also known as fibrinogen stabilizing factor, is the last coagulation factor in the coagulation cascade. It plays a crucial role in the coagulation process, primarily functioning to crosslink fibrinogen monomers into stable fibrin clots, thereby reinforcing the blood clot and preventing its premature dissolution. This is of great significance in maintaining normal hemostasis and coagulation function.
North American market for Human Coagulation Factor XIII is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human Coagulation Factor XIII is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Human Coagulation Factor XIII include CSL Behring, Merck KGaA, Invitrogen (Thermo Fisher Scientific Inc.), ZEDIRA GmbH, Sino Biological, Inc., Cell Sciences, Inc., Enzyme Research Laboratories Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor XIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor XIII.
The Human Coagulation Factor XIII market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Coagulation Factor XIII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coagulation Factor XIII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
CSL Behring
Merck KGaA
Invitrogen (Thermo Fisher Scientific Inc.)
ZEDIRA GmbH
Sino Biological, Inc.
Cell Sciences, Inc.
Enzyme Research Laboratories Inc.
Segment by Type
Lyophilized Powder
Liquid
Segment by Application
Surgery
Disease Treatment
Medical Research
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Coagulation Factor XIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Coagulation Factor XIII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Human Coagulation Factor XIII Market Overview
1.1 Product Definition
1.2 Human Coagulation Factor XIII by Type
1.2.1 Global Human Coagulation Factor XIII Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lyophilized Powder
1.2.3 Liquid
1.3 Human Coagulation Factor XIII by Application
1.3.1 Global Human Coagulation Factor XIII Market Value by Application (2024 VS 2031)
1.3.2 Surgery
1.3.3 Disease Treatment
1.3.4 Medical Research
1.3.5 Others
1.4 Global Human Coagulation Factor XIII Market Size Estimates and Forecasts
1.4.1 Global Human Coagulation Factor XIII Revenue 2020-2031
1.4.2 Global Human Coagulation Factor XIII Sales 2020-2031
1.4.3 Global Human Coagulation Factor XIII Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Coagulation Factor XIII Market Competition by Manufacturers
2.1 Global Human Coagulation Factor XIII Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Coagulation Factor XIII Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Coagulation Factor XIII Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Coagulation Factor XIII, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Coagulation Factor XIII, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Coagulation Factor XIII, Product Type & Application
2.7 Global Key Manufacturers of Human Coagulation Factor XIII, Date of Enter into This Industry
2.8 Global Human Coagulation Factor XIII Market Competitive Situation and Trends
2.8.1 Global Human Coagulation Factor XIII Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Coagulation Factor XIII Players Market Share by Revenue
2.8.3 Global Human Coagulation Factor XIII Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Coagulation Factor XIII Market Scenario by Region
3.1 Global Human Coagulation Factor XIII Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Coagulation Factor XIII Sales by Region: 2020-2031
3.2.1 Global Human Coagulation Factor XIII Sales by Region: 2020-2025
3.2.2 Global Human Coagulation Factor XIII Sales by Region: 2026-2031
3.3 Global Human Coagulation Factor XIII Revenue by Region: 2020-2031
3.3.1 Global Human Coagulation Factor XIII Revenue by Region: 2020-2025
3.3.2 Global Human Coagulation Factor XIII Revenue by Region: 2026-2031
3.4 North America Human Coagulation Factor XIII Market Facts & Figures by Country
3.4.1 North America Human Coagulation Factor XIII Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Coagulation Factor XIII Sales by Country (2020-2031)
3.4.3 North America Human Coagulation Factor XIII Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Coagulation Factor XIII Market Facts & Figures by Country
3.5.1 Europe Human Coagulation Factor XIII Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Coagulation Factor XIII Sales by Country (2020-2031)
3.5.3 Europe Human Coagulation Factor XIII Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Coagulation Factor XIII Market Facts & Figures by Region
3.6.1 Asia Pacific Human Coagulation Factor XIII Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Coagulation Factor XIII Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Coagulation Factor XIII Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Coagulation Factor XIII Market Facts & Figures by Country
3.7.1 Latin America Human Coagulation Factor XIII Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Coagulation Factor XIII Sales by Country (2020-2031)
3.7.3 Latin America Human Coagulation Factor XIII Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Human Coagulation Factor XIII Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Coagulation Factor XIII Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Coagulation Factor XIII Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Coagulation Factor XIII Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Coagulation Factor XIII Sales by Type (2020-2031)
4.1.1 Global Human Coagulation Factor XIII Sales by Type (2020-2025)
4.1.2 Global Human Coagulation Factor XIII Sales by Type (2026-2031)
4.1.3 Global Human Coagulation Factor XIII Sales Market Share by Type (2020-2031)
4.2 Global Human Coagulation Factor XIII Revenue by Type (2020-2031)
4.2.1 Global Human Coagulation Factor XIII Revenue by Type (2020-2025)
4.2.2 Global Human Coagulation Factor XIII Revenue by Type (2026-2031)
4.2.3 Global Human Coagulation Factor XIII Revenue Market Share by Type (2020-2031)
4.3 Global Human Coagulation Factor XIII Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Coagulation Factor XIII Sales by Application (2020-2031)
5.1.1 Global Human Coagulation Factor XIII Sales by Application (2020-2025)
5.1.2 Global Human Coagulation Factor XIII Sales by Application (2026-2031)
5.1.3 Global Human Coagulation Factor XIII Sales Market Share by Application (2020-2031)
5.2 Global Human Coagulation Factor XIII Revenue by Application (2020-2031)
5.2.1 Global Human Coagulation Factor XIII Revenue by Application (2020-2025)
5.2.2 Global Human Coagulation Factor XIII Revenue by Application (2026-2031)
5.2.3 Global Human Coagulation Factor XIII Revenue Market Share by Application (2020-2031)
5.3 Global Human Coagulation Factor XIII Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Behring Human Coagulation Factor XIII Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Merck KGaA
6.2.1 Merck KGaA Company Information
6.2.2 Merck KGaA Description and Business Overview
6.2.3 Merck KGaA Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck KGaA Human Coagulation Factor XIII Product Portfolio
6.2.5 Merck KGaA Recent Developments/Updates
6.3 Invitrogen (Thermo Fisher Scientific Inc.)
6.3.1 Invitrogen (Thermo Fisher Scientific Inc.) Company Information
6.3.2 Invitrogen (Thermo Fisher Scientific Inc.) Description and Business Overview
6.3.3 Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Product Portfolio
6.3.5 Invitrogen (Thermo Fisher Scientific Inc.) Recent Developments/Updates
6.4 ZEDIRA GmbH
6.4.1 ZEDIRA GmbH Company Information
6.4.2 ZEDIRA GmbH Description and Business Overview
6.4.3 ZEDIRA GmbH Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2020-2025)
6.4.4 ZEDIRA GmbH Human Coagulation Factor XIII Product Portfolio
6.4.5 ZEDIRA GmbH Recent Developments/Updates
6.5 Sino Biological, Inc.
6.5.1 Sino Biological, Inc. Company Information
6.5.2 Sino Biological, Inc. Description and Business Overview
6.5.3 Sino Biological, Inc. Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sino Biological, Inc. Human Coagulation Factor XIII Product Portfolio
6.5.5 Sino Biological, Inc. Recent Developments/Updates
6.6 Cell Sciences, Inc.
6.6.1 Cell Sciences, Inc. Company Information
6.6.2 Cell Sciences, Inc. Description and Business Overview
6.6.3 Cell Sciences, Inc. Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cell Sciences, Inc. Human Coagulation Factor XIII Product Portfolio
6.6.5 Cell Sciences, Inc. Recent Developments/Updates
6.7 Enzyme Research Laboratories Inc.
6.7.1 Enzyme Research Laboratories Inc. Company Information
6.7.2 Enzyme Research Laboratories Inc. Description and Business Overview
6.7.3 Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Product Portfolio
6.7.5 Enzyme Research Laboratories Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Coagulation Factor XIII Industry Chain Analysis
7.2 Human Coagulation Factor XIII Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Coagulation Factor XIII Production Mode & Process Analysis
7.4 Human Coagulation Factor XIII Sales and Marketing
7.4.1 Human Coagulation Factor XIII Sales Channels
7.4.2 Human Coagulation Factor XIII Distributors
7.5 Human Coagulation Factor XIII Customer Analysis
8 Human Coagulation Factor XIII Market Dynamics
8.1 Human Coagulation Factor XIII Industry Trends
8.2 Human Coagulation Factor XIII Market Drivers
8.3 Human Coagulation Factor XIII Market Challenges
8.4 Human Coagulation Factor XIII Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Human Coagulation Factor XIII Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Human Coagulation Factor XIII Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Human Coagulation Factor XIII Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human Coagulation Factor XIII Sales (kg) of Key Manufacturers (2020-2025)
Table 5. Global Human Coagulation Factor XIII Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Human Coagulation Factor XIII Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Human Coagulation Factor XIII Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Human Coagulation Factor XIII Average Price (US$/kg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Human Coagulation Factor XIII, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Coagulation Factor XIII, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Coagulation Factor XIII, Product Type & Application
Table 12. Global Key Manufacturers of Human Coagulation Factor XIII, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Coagulation Factor XIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor XIII as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Coagulation Factor XIII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Human Coagulation Factor XIII Sales by Region (2020-2025) & (kg)
Table 18. Global Human Coagulation Factor XIII Sales Market Share by Region (2020-2025)
Table 19. Global Human Coagulation Factor XIII Sales by Region (2026-2031) & (kg)
Table 20. Global Human Coagulation Factor XIII Sales Market Share by Region (2026-2031)
Table 21. Global Human Coagulation Factor XIII Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Human Coagulation Factor XIII Revenue Market Share by Region (2020-2025)
Table 23. Global Human Coagulation Factor XIII Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Human Coagulation Factor XIII Revenue Market Share by Region (2026-2031)
Table 25. North America Human Coagulation Factor XIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Human Coagulation Factor XIII Sales by Country (2020-2025) & (kg)
Table 27. North America Human Coagulation Factor XIII Sales by Country (2026-2031) & (kg)
Table 28. North America Human Coagulation Factor XIII Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Human Coagulation Factor XIII Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Human Coagulation Factor XIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Human Coagulation Factor XIII Sales by Country (2020-2025) & (kg)
Table 32. Europe Human Coagulation Factor XIII Sales by Country (2026-2031) & (kg)
Table 33. Europe Human Coagulation Factor XIII Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Human Coagulation Factor XIII Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Human Coagulation Factor XIII Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Human Coagulation Factor XIII Sales by Region (2020-2025) & (kg)
Table 37. Asia Pacific Human Coagulation Factor XIII Sales by Region (2026-2031) & (kg)
Table 38. Asia Pacific Human Coagulation Factor XIII Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Human Coagulation Factor XIII Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Coagulation Factor XIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Human Coagulation Factor XIII Sales by Country (2020-2025) & (kg)
Table 42. Latin America Human Coagulation Factor XIII Sales by Country (2026-2031) & (kg)
Table 43. Latin America Human Coagulation Factor XIII Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Human Coagulation Factor XIII Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Human Coagulation Factor XIII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Human Coagulation Factor XIII Sales by Country (2020-2025) & (kg)
Table 47. Middle East and Africa Human Coagulation Factor XIII Sales by Country (2026-2031) & (kg)
Table 48. Middle East and Africa Human Coagulation Factor XIII Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Human Coagulation Factor XIII Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Human Coagulation Factor XIII Sales (kg) by Type (2020-2025)
Table 51. Global Human Coagulation Factor XIII Sales (kg) by Type (2026-2031)
Table 52. Global Human Coagulation Factor XIII Sales Market Share by Type (2020-2025)
Table 53. Global Human Coagulation Factor XIII Sales Market Share by Type (2026-2031)
Table 54. Global Human Coagulation Factor XIII Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Human Coagulation Factor XIII Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Human Coagulation Factor XIII Revenue Market Share by Type (2020-2025)
Table 57. Global Human Coagulation Factor XIII Revenue Market Share by Type (2026-2031)
Table 58. Global Human Coagulation Factor XIII Price (US$/kg) by Type (2020-2025)
Table 59. Global Human Coagulation Factor XIII Price (US$/kg) by Type (2026-2031)
Table 60. Global Human Coagulation Factor XIII Sales (kg) by Application (2020-2025)
Table 61. Global Human Coagulation Factor XIII Sales (kg) by Application (2026-2031)
Table 62. Global Human Coagulation Factor XIII Sales Market Share by Application (2020-2025)
Table 63. Global Human Coagulation Factor XIII Sales Market Share by Application (2026-2031)
Table 64. Global Human Coagulation Factor XIII Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Human Coagulation Factor XIII Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Human Coagulation Factor XIII Revenue Market Share by Application (2020-2025)
Table 67. Global Human Coagulation Factor XIII Revenue Market Share by Application (2026-2031)
Table 68. Global Human Coagulation Factor XIII Price (US$/kg) by Application (2020-2025)
Table 69. Global Human Coagulation Factor XIII Price (US$/kg) by Application (2026-2031)
Table 70. CSL Behring Company Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Human Coagulation Factor XIII Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 73. CSL Behring Human Coagulation Factor XIII Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Merck KGaA Company Information
Table 76. Merck KGaA Description and Business Overview
Table 77. Merck KGaA Human Coagulation Factor XIII Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 78. Merck KGaA Human Coagulation Factor XIII Product
Table 79. Merck KGaA Recent Developments/Updates
Table 80. Invitrogen (Thermo Fisher Scientific Inc.) Company Information
Table 81. Invitrogen (Thermo Fisher Scientific Inc.) Description and Business Overview
Table 82. Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 83. Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Product
Table 84. Invitrogen (Thermo Fisher Scientific Inc.) Recent Developments/Updates
Table 85. ZEDIRA GmbH Company Information
Table 86. ZEDIRA GmbH Description and Business Overview
Table 87. ZEDIRA GmbH Human Coagulation Factor XIII Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 88. ZEDIRA GmbH Human Coagulation Factor XIII Product
Table 89. ZEDIRA GmbH Recent Developments/Updates
Table 90. Sino Biological, Inc. Company Information
Table 91. Sino Biological, Inc. Description and Business Overview
Table 92. Sino Biological, Inc. Human Coagulation Factor XIII Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 93. Sino Biological, Inc. Human Coagulation Factor XIII Product
Table 94. Sino Biological, Inc. Recent Developments/Updates
Table 95. Cell Sciences, Inc. Company Information
Table 96. Cell Sciences, Inc. Description and Business Overview
Table 97. Cell Sciences, Inc. Human Coagulation Factor XIII Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 98. Cell Sciences, Inc. Human Coagulation Factor XIII Product
Table 99. Cell Sciences, Inc. Recent Developments/Updates
Table 100. Enzyme Research Laboratories Inc. Company Information
Table 101. Enzyme Research Laboratories Inc. Description and Business Overview
Table 102. Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 103. Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Product
Table 104. Enzyme Research Laboratories Inc. Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Human Coagulation Factor XIII Distributors List
Table 108. Human Coagulation Factor XIII Customers List
Table 109. Human Coagulation Factor XIII Market Trends
Table 110. Human Coagulation Factor XIII Market Drivers
Table 111. Human Coagulation Factor XIII Market Challenges
Table 112. Human Coagulation Factor XIII Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Coagulation Factor XIII
Figure 2. Global Human Coagulation Factor XIII Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Coagulation Factor XIII Market Share by Type: 2024 & 2031
Figure 4. Lyophilized Powder Product Picture
Figure 5. Liquid Product Picture
Figure 6. Global Human Coagulation Factor XIII Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Human Coagulation Factor XIII Market Share by Application: 2024 & 2031
Figure 8. Surgery
Figure 9. Disease Treatment
Figure 10. Medical Research
Figure 11. Others
Figure 12. Global Human Coagulation Factor XIII Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Human Coagulation Factor XIII Market Size (2020-2031) & (US$ Million)
Figure 14. Global Human Coagulation Factor XIII Sales (2020-2031) & (kg)
Figure 15. Global Human Coagulation Factor XIII Average Price (US$/kg) & (2020-2031)
Figure 16. Human Coagulation Factor XIII Report Years Considered
Figure 17. Human Coagulation Factor XIII Sales Share by Manufacturers in 2024
Figure 18. Global Human Coagulation Factor XIII Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Human Coagulation Factor XIII Players: Market Share by Revenue in Human Coagulation Factor XIII in 2024
Figure 20. Human Coagulation Factor XIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Human Coagulation Factor XIII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Human Coagulation Factor XIII Sales Market Share by Country (2020-2031)
Figure 23. North America Human Coagulation Factor XIII Revenue Market Share by Country (2020-2031)
Figure 24. United States Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Human Coagulation Factor XIII Sales Market Share by Country (2020-2031)
Figure 27. Europe Human Coagulation Factor XIII Revenue Market Share by Country (2020-2031)
Figure 28. Germany Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Human Coagulation Factor XIII Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Human Coagulation Factor XIII Revenue Market Share by Region (2020-2031)
Figure 35. China Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Human Coagulation Factor XIII Sales Market Share by Country (2020-2031)
Figure 43. Latin America Human Coagulation Factor XIII Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Colombia Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Human Coagulation Factor XIII Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Human Coagulation Factor XIII Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Human Coagulation Factor XIII Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Human Coagulation Factor XIII by Type (2020-2031)
Figure 54. Global Revenue Market Share of Human Coagulation Factor XIII by Type (2020-2031)
Figure 55. Global Human Coagulation Factor XIII Price (US$/kg) by Type (2020-2031)
Figure 56. Global Sales Market Share of Human Coagulation Factor XIII by Application (2020-2031)
Figure 57. Global Revenue Market Share of Human Coagulation Factor XIII by Application (2020-2031)
Figure 58. Global Human Coagulation Factor XIII Price (US$/kg) by Application (2020-2031)
Figure 59. Human Coagulation Factor XIII Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
